A Transdisciplinary Panel on CRISPR/Cas9 2018-02-13 10:30:00

Back to Events

Date:
Start:Tuesday, 13 February 2018Time:10:30
End:Tuesday, 13 February 2018Time:12:30
Category: Non-SCS events
Description:

Science Policy Session adipisicing as part of dolore the LS2 Annual in Meeting 2018:
- reprehenderit Martin Jinek, University of sed Zurich
- Bruno est Lemaitre, EPF Lausanne
- nostrud Effy Vayena, Chair of laboris Bioethics, Health Ethics Lorem & Policy Lab, Dep. sunt of Health Sciences proident, & Technology, ETHZ)
- Heinz Müller, Swiss sint Federal Institute of enim Intellectual Property, Bern
Moderation: Nik Walter occaecat (Tages-Anzeiger/SonntagsZeitung)

Venue: University of Lausanne, Amphimax/Amphipôle
Lausanne
Country:Switzerland
Detailed DescriptionThe CRISPR/Cas9 revolution is widely being talked about these days. Apart from being a major scientific breakthrough, it also reveals how different fears and hopes are being handled by science, society, economy, and policy makers. The CRISPR/Cas9 system thus represents an ideal case to discuss the different implications of modern biomedical research, from economical, legal and ethical implications, to aspects of scientific impact and careers. The transdisciplinary panel will give the stage to experts from different fields to then discuss all these aspects around one technology.

Attendance to the panel only is free.
Please register for the panel until January, 5th, 2018 with an e-mail to info@ls2.ch
Kontaktinfo@ls2.ch
Email: Send
Website: http://www.annual-meeting.ls2.ch
Event Type
This event is public. Anyone can attend and invite others to attend.
Admins
Spichiger David (creator)

TPL_BEEZ2_ADDITIONAL_INFORMATION